Clinical trial
Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial
NCT06933381 is registered in ClinicalTrials.gov with Queen's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial
- Lead sponsor
- Queen's Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 16, 2025
- Completion date
- July 1, 2027
- Enrollment
- 70 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
reducing pain with nexplanon implant insertion